Clinical trial
A Real-world Study of Octreotide Microspheres in Chinese Patients With Neuroendocrine Tumors
NCT06300216 is registered in ClinicalTrials.gov with Qilu Hospital of Shandong University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Real-world Study of Octreotide Microspheres in Chinese Patients With Neuroendocrine Tumors
- Lead sponsor
- Qilu Hospital of Shandong University
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- March 26, 2024
- Completion date
- May 26, 2028
- Enrollment
- 500 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.